141 related articles for article (PubMed ID: 12859992)
1. Monitoring of hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation (alloSCT) by dual-color FISH analysis of X and Y chromosomes.
Turkiewicz D; Gorczynska E; Toporski J; Kalwak K; Rybka B; Noworolska D; Boguslawska-Jaworska J; Chybicka A
Leuk Res; 2003 Nov; 27(11):993-8. PubMed ID: 12859992
[TBL] [Abstract][Full Text] [Related]
2. [The clinical significance of interphase fluorescence in situ hybridization monitoring chimeric status after sex-mismatched allogeneic hematopoietic stem cell transplantation for leukemia].
Liu Q; Song L; Zhang Y; Wei Y; Xu D; Sun J; Liu X; Xu B; Meng F; Zhou S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):212-5. PubMed ID: 15793790
[TBL] [Abstract][Full Text] [Related]
3. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host disease.
Gyger M; Baron C; Forest L; Lussier P; Lagacé F; Bissonnette I; Bélanger R; Bonny Y; Busque L; Roy DC; Perreault C
Exp Hematol; 1998 May; 26(5):426-34. PubMed ID: 9590660
[TBL] [Abstract][Full Text] [Related]
6. Donor fibroblast chimerism in the pathogenic fibrotic lesion of human chronic graft-versus-host disease.
Ogawa Y; Kodama H; Kameyama K; Yamazaki K; Yasuoka H; Okamoto S; Inoko H; Kawakami Y; Kuwana M
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4519-27. PubMed ID: 16303943
[TBL] [Abstract][Full Text] [Related]
7. FISH detection of chimerism in pediatric hematopoietic stem cell transplantation.
Aydin F; Oguz F; Onal AE; Bilgen H; Oguz R; Anak S; Carin M; Gedikoglu G
Int J Lab Hematol; 2007 Jun; 29(3):208-14. PubMed ID: 17474899
[TBL] [Abstract][Full Text] [Related]
8. Detection of chimerism in subpopulations of cells by fluorescence in situ hybridization and immunofluorescent staining of cell surface antigens.
Gerritsen WR; Jagiello CA; Bourhis JH
Bone Marrow Transplant; 1994 Apr; 13(4):441-7. PubMed ID: 8019469
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of STR-PCR and FISH value for monitoring chimerism after sex-mismatched allogeneic hematopoietic stem cell transplantation].
Qin YW; Jiang Y; Wang XR; Wan LP; Yan SK; Wang C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1016-20. PubMed ID: 19698250
[TBL] [Abstract][Full Text] [Related]
10. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
[TBL] [Abstract][Full Text] [Related]
11. Early detection of relapse and evaluation of treatment for mixed chimerism using fluorescence in situ hybridization following allogeneic hematopoietic cell transplant for hematological malignancies.
Tamura S; Saheki K; Takatsuka H; Wada H; Fujimori Y; Okamoto T; Takemoto Y; Hashimoto-Tamaoki T; Furuyama J; Kakishita E
Ann Hematol; 2000 Nov; 79(11):622-6. PubMed ID: 11131921
[TBL] [Abstract][Full Text] [Related]
12. An internal validation approach and quality control on hematopoietic chimerism testing after allogeneic hematopoietic cell transplantation.
Waterhouse M; Kunzmann R; Torres M; Bertz H; Finke J
Clin Chem Lab Med; 2013 Feb; 51(2):363-9. PubMed ID: 23093278
[TBL] [Abstract][Full Text] [Related]
13. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].
Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):208-11. PubMed ID: 12812663
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.
Fehse B; Chukhlovin A; Kühlcke K; Marinetz O; Vorwig O; Renges H; Krüger W; Zabelina T; Dudina O; Finckenstein FG; Kröger N; Kabisch H; Hochhaus A; Zander AR
J Hematother Stem Cell Res; 2001 Jun; 10(3):419-25. PubMed ID: 11454317
[TBL] [Abstract][Full Text] [Related]
17. Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI).
Díez-Martín JL; Llamas P; Gosálvez J; López-Fernández C; Polo N; de la Fuente MS; Buño I
Haematologica; 1998 May; 83(5):408-15. PubMed ID: 9658724
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
[TBL] [Abstract][Full Text] [Related]
19. FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children.
Fuehrer M; Gerusel-Bleck M; Konstantopoulos N; Bender-Goetze C; Walther JU
Int J Mol Med; 2005 Feb; 15(2):291-7. PubMed ID: 15647846
[TBL] [Abstract][Full Text] [Related]
20. Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation.
Mueller RJ; Stussi G; Puga Yung G; Nikolic M; Soldini D; Halter J; Meyer-Monard S; Gratwohl A; Passweg JR; Odermatt B; Schanz U; Biedermann BC; Seebach JD
Haematologica; 2011 Jan; 96(1):119-27. PubMed ID: 20934999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
